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Background: Although pre-emptive analgesia is commonly used for the management of postoperative pain in
developed countries, no defined protocol has been carried out and widely practiced, especially in transabdominal
hysterectomy. Keeping this in mind the present study aimed to investigate the effects of multimodal pre-emptive
analgesia on pain management, stress response and inflammatory factors of patients undergoing transabdominal
hysterectomy to find an optimized way of pre-emptive analgesia.
Methods: One hundred patients undergoing abdominal hysterectomy were randomly divided into four groups
(Trial registration: ChiCTR-IPR-15005848). Group P1 was given intravenous flurbiprofen and epidural fentanyl + ketamine
before surgery; Group P2 received intravenous flurbiprofen before surgery and epidural fentanyl + ketamine after
surgery; Group P3 was given epidural fentanyl + ketamine before surgery and intravenous flurbiprofen after surgery;
Patients in Group C received normal saline treatment.
Results: Compared with control group, the first time to request additional analgesics after surgery were significantly
later (P <0.05), 24 h dosage of analgesia were significantly less (P <0.05), VAS score at all time periods after surgery
were significantly lower (P <0.05) in Group P1, P2, or P3. At 12 h or 24 h after surgery, VAS score in Group P1 was
significantly lower than that in group P2 or P3 (P <0.05, P <0.05). No significant adverse effects were found among the
groups (P > 0.05). At 1 or 2 days after surgery, the levels of cortisol, glucose, and IL-6, TNF-α in group P1, P2, and P3
were significantly lower than those in group C (P < 0.05); while, the levels in group P2, P3 were significantly lower than
those in group P1 (P < 0.05).
Conclusion: Multimodal pre-emptive analgesia could significantly lower VAS score, inhibit stress response, and reduce
inflammatory response in patients undergoing transabdominal hysterectomy, which can be a rational strategy for pain
control in future.
Trial registration: ChiCTR-IPR-15005848 on January 17, 2015.
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Transabdominal hysterectomy is an effective strategy for the
treatment of benign uterine diseases in primary hospitals,
but the operation effect and quality of life were unsatisfac-
tory with large operation trauma, consistent postoperative
pain, and adverse postoperative rehabilitation. Besides, for
patients undergoing abdominal hysterectomy, stress re-
sponse and inflammatory reaction harmful for rehabilitation
may be also induced by the operation trauma, which mani-
fested as elevated blood pressure, heart rate and blood glu-
cose, and the release of inflammatory factors, such as IL-6
and TNF-α.
Pre-emptive analgesia is a way of pain intervention be-
fore noxious stimulation which has been reported to be
potent to relieve the postoperative pain by relieving the
pain of peripheral and central sensitization [1]. However,
the pathogenesis of postoperative pain is complicated in-
volving inflammatory, neurogenic, and visceral mecha-
nisms, and single-mode analgesic medication is not quite
efficient [2]. The combination of different analgesic drugs
and different methods of analgesia (multimodal pre-
emptive analgesia) is a relatively novel method for pain
intervention. Though many studies have been reported on
multimodal pre-emptive analgesia, no consensus has been
achieved, and the effects on stress response and inflamma-
tory reaction related with multimodal pre-emptive anal-
gesia are seldom reported.
Therefore, in the present study, we aimed to find the
effects of multimodal pre-emptive analgesia by different
combination of preoperative and postoperative analgesic
drugs on pain control, stress response and inflammatory
factors of patients undergoing transabdominal hysterec-
tomy which may provide reference for clinical analgesia.
Methods
Patients
The sample size was determined by using the statistical
software program PASS 2008 (NCSS, Kaysville, UT, USA)
using preliminary data obtained in our hospital with the
following assumptions: α of 0.05 (two-tailed), power of
90%, P1 (Treatment Group Proportion) of 0.7, and P2
(Control Group Proportion) of 0.2. Therefore, a minimum
of 18 patients per group was calculated.
One hundred female patients who require transabdom-
inal hysterectomy were enrolled in this randomized and
double-blind study from the department of anesthesiology,
the Affiliated Jiangyin Hospital of Nantong University,
Jiangyin, Jiangsu, China, with approval from the medical
Ethics Committee of the Affiliated Jiangyin Hospital of
Nantong University and written consent obtained from
the participants. The inclusion criteria were physical status
American Society of Anesthesiologists (ASA) I- II, aged
between 30 and 55 years (mean age of 46.54 ± 8.72),
weighted between 50 and 75 kilogram (mean weight of62.52 ± 12.49 kg) undergoing transabdominal hysterec-
tomy, and the operation time was between 55 and 80 min
(mean time of 67.39 ± 12.74 min). Exclusion criteria were
contraindication for epidural puncture, known allergy to
local anesthetics, the patients with previous history of
hypertension, diabetes, coronary heart disease or other
medical history, the patients consumed opioids and non-
steroidal anti-inflammatory drugs (NSAIDs) preopera-
tively, and patients with physiological and psychological
disorders. A random allocation number table was used for
grouping the patients by two experienced chief physician:
control group (Group C), multimodal pre-emptive anal-
gesia group 1 (Group P1), multimodal pre-emptive anal-
gesia group 2 (Group P2), and multimodal pre-emptive
analgesia group 3 (Group P3). All patients had benign le-
sions of the uterus, where 83 cases of uterine fibroids, 12
cases of adenomyosis, and 5 cases of endometriosis. No
significant difference was found between the groups of pa-
tients in age, weight, operation time or history (P > 0.05).
The participants, care providers, those assessing outcomes
were blinded after assignment to interventions.
Methods
Patients were pre-medicated before anesthesia induction
with intramuscular 0.1 mg luminal and 0.5 mg atropine
30 min before operation. After entering the operation
room, vital signs of the patients were monitored, peripheral
vein was incised, and L2–3 lumbar epidural anesthesia was
used at the left lateral decubitus position; 3 ml of 0.5%
bupivacaine (2 ml of 0.75% bupivacaine and 1 ml of cere-
brospinal fluid) was treated at the subarachnoid space; the
anesthesia was adjusted below the T8 level; if anesthesia is
low, 1.2% lidocaine was treated at the epidural space.
Patients were allocated randomly into one of four
groups (25 cases for each group): Patients in Group C
(control group) received 5 ml normal saline intraven-
ously before and after surgical operation and 10 ml nor-
mal saline epidurally; Patients in group P1 received
50 mg flurbiprofen (Beijing TIDE Pharmaceutical
Co.,Ltd, Beijing, China) intravenously and 1.0 μg/kg
fentanyl (Yichang Humanwell Pharmaceutical Co.,Ltd,
Hubei, China) + 0.25 mg/kg ketamine (Fujian Gutian
Pharmaceutical Co.,Ltd, Fujian, China) epidurally before
surgical operation, and 5 ml normal saline intravenously
and 10 ml normal saline epidurally after surgical oper-
ation; Patients in group P2 received 50 mg flurbiprofen
intravenously and 10 ml normal saline epidurally before
surgical operation, and 5 ml normal saline intravenously
and 1.0 μg/kg fentanyl + 0.25 mg/kg ketamine epidurally
after surgical operation; Patients in group P3 received
5 ml normal saline intravenously and 1.0 μg/kg fentanyl +
0.25 mg/kg ketamine epidurally before surgical operation,
and 50 mg flurbiprofen intravenously and 10 ml normal
saline epidurally after surgical operation.
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through traditional abdominal incision in the lower ab-
domen, and the surgical procedure was similar in all pa-
tients, including skin incision, presence and duration of
drainage, hospital stay, etc.
Patient-controlled analgesia was used after surgery for
all patients: 2 ml/h continuous infusion of 10 μg/kg/
100 ml fentanyl (a bolus of 1 ml with a lock-time of
15 min) by using Electronics pump (Shanghai Bochuang
Co., Ltd).
We did not make any changes to trial outcomes after
the trial commenced, because no significant adverse ef-
fects were found in all patients.
Evaluation indexes
All study–related measurements were taken by the same
anesthesiologist who was not aware of the treatment alloca-
tion of the patients. The first time to request additional an-
algesics by pressing the patient-controlled analgesia after
surgery was recorded. Pain scores on a visual analogue scale
(VAS; 0 = no pain, 10 =worst pain imaginable) were re-
corded at 6 h, 12 h, 24 h, and 48 h after operation. The
24 h dosage of analgesia and adverse reactions were
recorded.
Outcome measures
Stress response and inflammatory factors of each patient
in groups were measured before surgery (8:00 am), 1d
postoperative (8:00 am), and 2d postoperative (8:00 am).
Stress response was expressed as the concentration ofFigure 1 CONSORT flow diagram.cortisol (Cor) and glucose (Glu). The inflammatory cyto-
kines in serum (IL-6 and TNF-α) were analyzed by com-
mercial ELISA kits (Simens Healthcare Diagnostics
Products, Gwynedd, United Kingdom).Statistical analysis
The size calculation for each group was as follows: Group
C, 24 cases; Group P1, 24 cases; Group P2, 25 cases;
Group P3, 25 cases. Statistical analysis was performed by
the SPSS16.0 software (SPSS Inc., Chicago, IL, USA). Data
were presented as mean ± SD. Patient characteristics (i.e.,
age, BMI, fasting plasma glucose, HbA1C, and operating
time) were analyzed using the independent t-test. The dif-
ferences between the groups were compared by using ana-
lysis of variance (ANOVA). The result was considered
statistically significant when P < 0.05.Results
Patients
One hundred female patients were enrolled in this random-
ized and double-blind study from July 2011 to February
2014, and all participants received intended treatment. One
patient in group C and one patient in group P1 were ex-
cluded for hypopiesia and shock during operation. So data
from 98 patients was available for analysis. The CONSORT
flow diagram was shown in Figure 1.
The characteristics of participants undergoing transab-
dominal hysterectomy in four groups were shown in
Table 1.
Table 1 Characteristics of participants undergoing transabdominal hysterectomy in four groups
Characteristic Group C (n = 24) Group P1 (n = 24) Group P2 (n = 25) Group P3 (n = 25)
Age (years) 46.72 ± 9.34 45.89 ± 7.82 47.21. ± 8.73 47.42 ± 9.26
BMI (kg/m2) 22.64 ± 0.84 23.05 ± 0.76 22.81 ± 0.92 22.74 ± 0.69
Fasting plasma glucose (mmol/l) 5.36 ± 0.48 5.21 ± 0.55 5.42 ± 0.61 5.29 ± 0.39
HbA1C (%) 4.86 ± 0.72 4.83 ± 0.67 4.91 ± 0.58 4.94 ± 0.62
Operating time (min) 66.89 ± 11.72 68.58 ± 13.54 67.51 ± 12.73 68.31 ± 12.86
Data is expressed as mean ± SD. BMI, body mass index. No significant differences among the groups.
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surgery and the 24 h dosage of analgesia
The first time to request additional analgesics after sur-
gery in Group P1, P2 and P3 were significantly later than
that in control group (P <0.05), and no significant differ-
ence was found among Group P1, P2 and P3 (P >0.05).
The 24 h dosage of analgesia in Group P1, P2 and P3
was significantly less than that in Group C (P <0.05),
and no significant difference was found among Group
P1, P2 and P3 (P > 0.05) (As shown in Table 2).
VAS scores after surgery
At 6 h, 12 h, and 24 h after surgery, VAS score in Group
P1, P2, or P3 was significantly lower than that in group C
(P <0.05, P <0.05, P <0.05). At 12 h and 24 h after surgery,
VAS score in Group P1 was significantly lower than that in
group P2 or P3 (P <0.05, P <0.05) (As shown in Table 3).
Adverse effect
The patients having nausea after operation were as fol-
lows: Group P1, 3 cases; Group P2, 3 cases; Group P3, 5
cases; Group C, 4 cases. No vomiting, pruritus, or psychi-
atric symptoms reactions were found in all patients of the
four groups. No significant adverse effects were found
among the four groups (P > 0.05).
The level of cortisol and glucose in groups
There was no significant difference in serum level of corti-
sol or glucose between the groups before the surgery (P >
0.05). 1d and 2d postoperative, both the serum level of cor-
tisol and level of glucose in Group P1, P2 and P3 were sig-
nificantly lower than that in Group C (P < 0.05); and the
level of cortisol and level of glucose in Group P2 and P3
were significantly lower than that in Group P1 (P < 0.05)
(shown in Table 4).Table 2 The first time to request additional analgesics after s
Groups Cases Initial press tim
Group P1 24 8.03 ± 1.56*
Group P2 24 7.97 ± 1.62*
Group P3 25 7.99 ± 1.77*
Group C 25 6.81 ± 1.65
Note: *P < 0.05, compared with Group C.The level of inflammatory factors (IL-6 and TNF-α)
There was no significant difference in serum level of IL-
6 or TNF-α between the groups before the surgery (P >
0.05). One day or two days after operation, both the
serum level of IL-6 and level of TNF-α in Group P1, P2
and P3 were significantly lower than that in Group C (P
< 0.05); and the level of IL-6 and level of TNF-α in
Group P2 and P3 were significantly lower that that in
Group P1 (P < 0.05) (shown in Table 5).
Discussion
Postoperative pain is caused by the association of many
factors, including physical injury by surgical incisions,
secondary inflammation, visceral pain stimulation, and
pain stimulation of nerve endings or central neurons [3].
Therefore, postoperative pain treatment should be com-
bined with comprehensive measures to improve the an-
algesic effect and reduce adverse reactions. Perioperative
pain can cause systemic stress response, and stimulate
the release of IL-6, TNF-α and other cytokines involved
in inflammation and immune response by mononuclear
macrophages and neutrophils. Studies have shown that
adequate analgesia can reduce the level of stress re-
sponse, reduce immune function suppression and pro-
mote postoperative rehabilitation.
Pre-emptive analgesia, first introduced by Woolf [4] in
1983, is an antinociceptive treatment that reduces central
sensitization and prevents establishment of altered process-
ing of afferent input, which amplifies postoperative pain.
Pre-emptive analgesia is found to be potent in preventing
severe pain perception which may develop postoperatively
[5]. Despite advances in pre-emptive anesthesia and anal-
gesia along with improved delivery systems, single-mode
analgesia continues to be the mainstay for treatment of
postoperative pain. However, single-mode analgesia such asurgery and 24 h dosage of analgesia





Table 3 VAS scores at different time period after surgery (x ± s)
Group Cases 6 h after surgery 12 h after surgery 24 h after surgery 48 h after surgery
Group C 24 2.78 ± 0.85 3.64 ± 0.74 3.79 ± 0.87 3.02 ± 0.71
Group P1 24 2.54 ± 0.81* 2.69 ± 0.78*& 3.03 ± 0.97*& 2.96 ± 0.78
Group P2 25 2.57 ± 0.79* 2.79 ± 0.81* 3.52 ± 0.84* 2.94 ± 0.73
Group P3 25 2.55 ± 0.77* 2.83 ± 0.69* 3.49 ± 0.79* 2.99 ± 0.67
Note: *P < 0.05, compared with Group C. &P <0.05, compared with Group P2 and P3.
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increase in the incidence of adverse events [6]. In the last
two decades, evidence-based multimodal analgesia has
become increasingly widespread [7]. Multimodal analgesia
refers to the combination of different mode of analgesic
drugs and incorporation of regional anesthesia to reduce
the peripheral and central pain sensitization, and it is a
promising alternative that may reduce needs for high doses
and dependence on analgesia drugs along with any poten-
tial associated adverse effects [2,3]. Therefore, we speculate
that the combination of multimodal analgesia and pre-
emptive analgesia (multimodal pre-emptive analgesia) may
have a better analgesic effect on pain management, reflected
by an improved pain scoring, and a reduction of side-
effects compared to the morphine group. The aim of this
study was to evaluate multimodal pre-emptive analgesia
consisting of flurbiprofen, fentanyl and ketamine intraven-
ously or epidurally in patients undergoing transabdominal
hysterectomy, and to find the possible mechanisms by ex-
ploring the effects on stress response and inflammatory
factors.
In this study, intravenous flurbiprofen, and epidural
fentanyl with ketamine were used for pre-emptive anal-
gesia study, and patient-controlled analgesia with fen-
tanyl was used after surgery. The results shows that both
pre-emptive analgesia with intravenous flurbiprofen, and
epidural fentanyl with ketamine can significantly extend
initial press time of analgesia, significantly reduce 24 h
dosage of analgesia, and significantly reduce 6 h, 12 h, and
24 h VAS scores after surgery, indicating the pre-emptive
analgesia effects of different analgesic drugs intravenously
or epidurally which is consistent with most reported liter-
atures [8-10]. Flurbiprofen, Fentanyl and Ketamine are
three different modes of analgesia drugs. Flurbiprofen, a
member of the phenylalkanoic acid derivative family ofTable 4 The level of cortisol and glucose in each group befor
Groups Cases Glu (mmol/L)
before surgery 1d after surgery 2d after
Group C 24 4.86 ± 0.54 6.89 ± 1.24& 6.28 ± 0.7
Group P1 24 4.83 ± 0.49 6.64 ± 0.62*& 6.03 ± 0.6
Group P2 25 4.85 ± 0.59 6.33 ± 0.67* 5.84 ± 0.5
Group P3 25 4.81 ± 0.62 6.35 ± 0.59* 5.79 ± 0.4
Note: *P <0.05, compared with Group C; &P <0.05, compared with Group P2 and P3non-steroidal anti-inflammatory drugs (NSAIDs) used to
treat inflammation, has been shown to have pre-emptive
analgesia effects by clinical studies [8]. Fentanyl is com-
monly used as a potent, synthetic opioid analgesic with a
rapid onset and short duration of action. Latest studies
demonstrated that pre-emptive low dose of fentanyl could
effectively prevent fentanyl-induced cough [9,11]. Epidural
Fentanyl has also been shown to have pre-emptive anal-
gesia effects. Ketamine is as an N-Methyl-D-aspartate
(NMDA) receptor antagonist. Sub-anesthetic doses of epi-
dural ketamine can significantly reduce intraoperative and
postoperative pain, but 0.15 mg/kg ketamine was reported
not efficient in inducing pre-emptive analgesia [12]. In the
present study, we find the possible synergistic effect of
epidural fentanyl with ketamine in pre-emptive analgesia.
Besides, we find significant lower VAS score with multi-
modul pre-emptive analgesia compared with single mode
pre-emptive analgesia, suggesting the possible synergistic
effect of multimodal pre-emptive analgesia drugs. We find
no significant difference of initial press time of analgesia,
24 h dosage of analgesia, and adverse reactions between
multimodal pre-emptive analgesia group and single mode
pre-emptive analgesia group, which may be limited to the
small amounts of patients, but also suggesting that the
safety of intravenous flurbiprofen, epidural fentanyl and
ketamine.
Glucose and cortisol are two common indicators
widely used for evaluating stress response of body. The
higher level of glucose and cortisol indicate the stronger
stress response. In the study, we find that 1d and 2d
postoperative, both the serum level of cortisol and level
of glucose in Group P1, P2 and P3 were significantly
lower than that in Group C (P < 0.05) and that in Group
P2 and P3 were significantly lower that that in Group
P1 (P < 0.05) (Table 3), suggesting that multi-mode pre-e and after surgery
Cor (ng/ml)
surgery before surgery 1d after surgery 2d after surgery
2& 169.54 ± 46.37 235.64 ± 69.57& 206.52 ± 64.37&
9*& 165.84 ± 54.36 212.47 ± 57.69*& 184.77 ± 60.51*&
7* 172.41 ± 62.38 188.74 ± 64.28* 177.58 ± 57.46*
8* 167.58 ± 58.32 191.86 ± 72.58* 174.23 ± 67.83*
.
Table 5 The level of IL-6 and TNF-α in each group before and after surgery
Groups Cases IL-6 (pg/ml) TNF-α (ng/ml)
Before surgery 1d after surgery 2d after surgery Before surgery 1d after surgery 2d after surgery
Group C 24 45.26 ± 5.74 78.48 ± 9.46& 66.38 ± 7.52& 0.88 ± 0.18 1.49 ± 0.16& 1.38 ± 0.17&
Group P1 24 46.35 ± 6.27 71.42 ± 8.79*& 61.58 ± 5.82*& 0.86 ± 0.13 1.42 ± 0.12*& 1.33 ± 0.13*&
Group P2 25 45.81 ± 5.93 65.81 ± 7.68* 54.71 ± 6.24* 0.87 ± 0.15 1.37 ± 0.13* 1.26 ± 0.11*
Group P3 25 47.62 ± 7.13 64.98 ± 8.67* 55.78 ± 7.62* 0.85 ± 0.16 1.36 ± 0.14* 1.25 ± 0.12*
Note: *P <0.05, compared with Group C; &P <0.05, compared with Group P2 and P3.
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postoperative stress response, and the combination of
analgesia drugs with multi-mode mechanisms by differ-
ent routes of administration shows significant inhibition
on stress response, which may be related to the inhib-
ition of pain generation.
IL-6 is an interleukin that acts as a pro-inflammatory
cytokine and plays an important role in nerve- endocrine-
immune system. IL-6, a functional cytokine with biological
activity closely, is associated with immune status, surgical
trauma and prognosis. TNF-α is a cytokine with a variety of
endogenous biological activity, regulating the inflammatory
response and immune response. The elevation of TNF-α is
associated with surgical trauma and intensity of pain stimu-
lus. In the study, we found that 1d and 2d postoperative,
both the serum level of IL-6 and level of TNF-α in Group
P1, P2 and P3 were significantly lower than that in Group
C (P < 0.05); and that in Group P2 and P3 were significantly
lower that that in Group P1 (P < 0.05) (Table 4), indicating
that multi-mode pre-emptive analgesia can effectively sup-
press postoperative inflammatory reaction in transabdom-
inal hysterectomy, and the combination of analgesia drugs
with multi-mode mechanisms by different routes of admin-
istration shows better analgesic effect.
Stress response and inflammatory response are always
existed before postoperative rehabilitation. The duration
of pre-emptive analgesia should include the entire
period of noxious stimuli acting on the central nervous
system (central sensitization and postoperative inci-
sional pain caused by surgery, and secondary inflamma-
tion). However, in the present study, we only observe
the effects at 1 day and 2 days after surgery which is a
limitation. However, our preliminary study showed that
multimodal pre-emptive analgesia was better than a
single-mode pre-emptive analgesia without increasing
adverse reactions, and multimodal pre-emptive anal-
gesia could significantly lower VAS score, inhibit stress
response, and reduce inflammatory response in patients
undergoing transabdominal hysterectomy. Though the
ideal multimodal pre-emptive analgesic drugs and mode
of administration are still not standardized, we believe
that with further elucidation in function of the dorsal
root ganglia, the development of molecular biology and
pain mechanisms, the ideal multimodal pre-emptiveanalgesia will be an important strategy for pain control
clinically.
Conclusions
The preliminary study showed that multimodal pre-
emptive analgesia was better than a single-mode pre-
emptive analgesia without increasing adverse reactions,
and multimodal pre-emptive analgesia could significantly
lower VAS score, inhibit stress response, and reduce in-
flammatory response in patients undergoing transabdom-
inal hysterectomy, demonstrating that multimodal pre-
emptive analgesia could be a rational strategy for pain
control. However, the ideal multimodal pre-emptive anal-
gesic drugs and mode of administration are far from stan-
dardized which need to be further studied in future.
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